The diagnostic accuracy of 18F-Fluorodeoxyglucose PET/CT in patients with gynecological malignancies

被引:56
|
作者
Grisaru, D
Almog, B
Levine, C
Metser, U
Fishman, A
Lerman, H
Lessing, JB
Even-Sapir, E
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Obstet & Gynecol, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Dept Radiol, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Sourasky Med Ctr, Dept Nucl Med, IL-64239 Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Meir Med Ctr, Dept Obstet & Gynecol, IL-69978 Tel Aviv, Israel
关键词
positron emission tomography/computerized tomography; staging; follow-up;
D O I
10.1016/j.ygyno.2004.05.053
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To evaluate the diagnostic accuracy of integrated positron emission tomography/computerized tomography (PET/CT) in patients with gynecological cancer. Methods. Fifty-three consecutive patients with gynecologic malignancies were included. The patients were referred to our tertiary center to undergo a PET/CT scan. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT were compared with the conventional imaging assessments [CT, magnetic resonance imaging (MRI) and ultrasonography (US)]. Results. All tested values were higher for PET/CT than those for the conventional modalities: sensitivity 0.97 vs. 0.40, specificity 0.94 vs. 0.65, PPV 0.97 vs. 0.70, and NPV 0.94 vs. 0.34, respectively. Conclusion. PET/CT is a reliable modality for assessing the extent of disease in patients with gynecologic malignancy. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:680 / 684
页数:5
相关论文
共 50 条
  • [21] 18F-fluorodeoxyglucose and 131I Radioguided Surgical Management of Thyroid Cancer
    Francis, Carrie L.
    Nalley, Chuck
    Fan, Chris
    Bodenner, Donald
    Stack, Brendan C., Jr.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 146 (01) : 26 - 32
  • [22] 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
    Casulo, Carla
    Schoeder, Heiko
    Feeney, John
    Lim, Remy
    Maragulia, Jocelyn
    Zelenetz, Andrew D.
    Horwitz, Steven
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2163 - 2167
  • [23] 18F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis
    Jansen, I.
    Hendriksz, T. R.
    Han, S. H.
    Huiskes, A. W. L. C.
    van Bommel, E. F. H.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (03) : 216 - 221
  • [24] Diagnostic and Clinical Significance of F-18-FDG-PET/CT Thyroid Incidentalomas
    Bertagna, Francesco
    Treglia, Giorgio
    Piccardo, Arnoldo
    Giubbini, Raffaele
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11): : 3866 - 3875
  • [25] Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?
    Mirpour, S.
    Meteesatien, P.
    Khandani, A. H.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2012, 31 (02): : 71 - 77
  • [26] Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma
    Le Dortz, Ludovic
    De Guibert, Sophie
    Bayat, Sahar
    Devillers, Anne
    Houot, Roch
    Rolland, Yan
    Cuggia, Marc
    Le Jeune, Florence
    Bahri, Haifa
    Barge, Marie-Luce
    Lamy, Thierry
    Garin, Etienne
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2307 - 2314
  • [27] Diagnostic Utility of 18F-FDG PET/CT in Inflammation of Unknown Origin
    Balink, Hans
    Bennink, Roel J.
    Veeger, Nic J. G. M.
    van Eck-Smit, Berthe L. F.
    Verberne, Hein J.
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (05) : 419 - 425
  • [28] Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative 131I whole body scan: evaluation by thyroglobulin level
    Na, Sae Jung
    Yoo, Ie Ryung
    O, Joo Hyun
    Lin, Chenghe
    Lin, Qiuyu
    Kim, Sung Hoon
    Chung, Soo Kyo
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (01) : 26 - 34
  • [29] [F-18]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy
    Samim, Morsal
    El-Haddad, Ghassan E.
    Molenaar, Izaak Quintes
    Prevoo, Warner
    van den Bosch, Maurice A. A. J.
    Alavi, Abass
    Lam, Marnix G. E. H.
    PET CLINICS, 2014, 9 (04) : 469 - 495
  • [30] Clinical utility of 18F-FDG PET for patients with salivary gland malignancies
    Roh, Jong-Lyel
    Ryu, Chang Hwan
    Choi, Seung-Ho
    Kim, Jae Seung
    Lee, Jeong Hyun
    Cho, Kyung-Ja
    Nam, Soon Yuhl
    Kim, Sang Yoon
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (02) : 240 - 246